Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance

Cancer Genetics and Cytogenetics

Volumn 132, Issue 1, 2002, Pages 25-29

  Lloveras, Elisabet ^a   Solé, Francesc ^a   Florensa, Lourdes ^a   Besses, Carles ^b   Espinet, Blanca ^a   Gil, Miguel ^b   Pérez Vila, Ma Encarnación ^a   Pedro, Carmen ^b   Abella, Eugènia ^b   Sans Sabrafen, Jordi ^b   Woessner, Soledad ^a  

^a Del Mar University   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD32 ANTIGEN; IMMUNOGLOBULIN A; MYELOPEROXIDASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CELL STRUCTURE; CHROMOSOME 11; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPING; MITOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MONOSOMY; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; ANTIGENS, CD3; BONE MARROW; CELLS, CULTURED; CHROMOSOME ABERRATIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MONOSOMY; MULTIPLE MYELOMA; PARAPROTEINS; PEROXIDASE;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0036162955     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00511-8     Document Type: Article

References (27)

1. "Benign" monoclonal gammopathy: After 20 to 35 years of follow-up
2. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance
3. Multiple myeloma: Increasing evidence for a multistep transformation process
4. Molecular alterations of IL6R, lck, and c-myc genes in transforming monoclonal gammopathies of undetermined significance
5. The use of biological variables to predict outcome in multiple myeloma
6. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
7. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases
8. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma
9. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in Southeastern Netherlands
10. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy
11. Prognosis in monoclonal gammopathy of undetermined significance
12. Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component
13. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance
14. Monoclonal gammopathy of undetermined significance: Chromosome changes are a common finding within bone marrow plasma cells
15. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition
16. Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization
17. Multiple myeloma: Almost all patients are cytogenetically abnormal
18. Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
19. A method for simultaneous study of the karyotype, morphology and immunologic phenotype of mitotic cells in hematologic malignancies
20. Ploidy and proliferative characteristics in monoclonal gammopathies
21. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: A report on 46 patients
22. Cytogenetic study in multiple myeloma at diagnosis: Comparison of two techniques
23. Cytogenetic study of 30 patients with multiple myeloma: Comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniturized karyotypic method
24. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases
25. Chromosome analysis in 2000 peripheral blood samples
26. May-Grünwald-Giemsa fluorescence in situ hybridization technique applied to a plasma cell leukemia